CROTTI, LIA
 Distribuzione geografica
Continente #
NA - Nord America 12.318
EU - Europa 6.655
AS - Asia 4.569
SA - Sud America 360
AF - Africa 58
OC - Oceania 37
Continente sconosciuto - Info sul continente non disponibili 7
Totale 24.004
Nazione #
US - Stati Uniti d'America 12.152
SG - Singapore 1.962
RU - Federazione Russa 1.618
IT - Italia 1.409
CN - Cina 1.118
HK - Hong Kong 896
IE - Irlanda 869
SE - Svezia 698
DE - Germania 669
GB - Regno Unito 374
BR - Brasile 275
ID - Indonesia 229
UA - Ucraina 216
FR - Francia 144
CA - Canada 126
NL - Olanda 106
AT - Austria 103
ES - Italia 99
JP - Giappone 81
FI - Finlandia 72
IN - India 71
DK - Danimarca 59
VN - Vietnam 59
AR - Argentina 43
CH - Svizzera 39
BE - Belgio 38
MX - Messico 33
TR - Turchia 27
AU - Australia 26
GR - Grecia 25
PL - Polonia 23
PT - Portogallo 23
ZA - Sudafrica 19
CO - Colombia 18
RO - Romania 15
CL - Cile 11
LT - Lituania 11
NZ - Nuova Zelanda 11
BD - Bangladesh 10
IR - Iran 10
KR - Corea 10
TW - Taiwan 10
CZ - Repubblica Ceca 8
AE - Emirati Arabi Uniti 7
IL - Israele 7
IQ - Iraq 7
SC - Seychelles 7
HR - Croazia 6
MA - Marocco 6
RS - Serbia 6
SA - Arabia Saudita 6
TH - Thailandia 6
EC - Ecuador 5
KW - Kuwait 5
KZ - Kazakistan 5
MY - Malesia 5
NG - Nigeria 5
NO - Norvegia 5
PH - Filippine 5
A2 - ???statistics.table.value.countryCode.A2??? 4
AZ - Azerbaigian 4
BG - Bulgaria 4
DZ - Algeria 4
EG - Egitto 4
UZ - Uzbekistan 4
AM - Armenia 3
BY - Bielorussia 3
CY - Cipro 3
EU - Europa 3
HU - Ungheria 3
KE - Kenya 3
LK - Sri Lanka 3
PK - Pakistan 3
SI - Slovenia 3
SN - Senegal 3
BO - Bolivia 2
CR - Costa Rica 2
DO - Repubblica Dominicana 2
ET - Etiopia 2
GE - Georgia 2
GH - Ghana 2
JO - Giordania 2
KG - Kirghizistan 2
MT - Malta 2
OM - Oman 2
PE - Perù 2
PY - Paraguay 2
SK - Slovacchia (Repubblica Slovacca) 2
AL - Albania 1
HN - Honduras 1
JM - Giamaica 1
KH - Cambogia 1
LA - Repubblica Popolare Democratica del Laos 1
LB - Libano 1
LV - Lettonia 1
MD - Moldavia 1
ML - Mali 1
MN - Mongolia 1
MU - Mauritius 1
PA - Panama 1
Totale 24.000
Città #
Fairfield 1.558
Singapore 1.352
Ann Arbor 1.273
Hong Kong 874
Dublin 817
Chandler 740
Ashburn 728
Woodbridge 698
Wilmington 674
Houston 595
Seattle 588
Santa Clara 506
Dearborn 501
Cambridge 492
Frankfurt am Main 425
New York 425
Milan 404
Princeton 363
Jakarta 223
Nanjing 171
Lawrence 161
Jacksonville 153
Altamura 152
Moscow 148
Council Bluffs 116
Beijing 109
San Diego 103
Vienna 79
London 75
Nuremberg 75
Guangzhou 74
Rome 70
Hefei 63
Shenyang 61
Hebei 60
Andover 57
Shanghai 56
Toronto 56
Nanchang 55
Jinan 53
São Paulo 49
Helsinki 46
Zhengzhou 36
Dong Ket 35
Boardman 33
Los Angeles 33
Tianjin 33
Chicago 32
Jiaxing 32
Tokyo 31
Changsha 28
Norwalk 28
Phoenix 28
Madrid 27
Hangzhou 26
Ottawa 26
Amsterdam 23
Ningbo 22
The Dalles 21
San Francisco 20
Buenos Aires 19
Belo Horizonte 17
Brussels 17
Castano Primo 17
Copenhagen 13
Groningen 13
Kunming 13
Modena 13
Upper Marlboro 13
Verona 13
Washington 13
Wuhan 13
Zurich 13
Central 12
Florence 12
Hyderabad 12
Lappeenranta 12
Pavia 12
Pune 12
Silver Spring 12
Atlanta 11
Bogotá 11
Bologna 11
Clearwater 11
Edmonton 11
Genoa 11
Lisbon 11
Mexico City 11
Munich 11
Naples 11
Athens 10
Falls Church 10
Huizen 10
Padova 10
Redmond 10
Sydney 10
Taizhou 10
Turin 10
Turku 10
Voghera 10
Totale 16.273
Nome #
Indications and utility of cardiac genetic testing in athletes 435
Elucidating arrhythmogenic mechanisms of long-QT syndrome CALM1-F142L mutation in patient-specific induced pluripotent stem cell-derived cardiomyocytes 379
International Triadin Knockout Syndrome Registry: The Clinical Phenotype and Treatment Outcomes of Patients with Triadin Knockout Syndrome 348
Calmodulinopathy: A Novel, Life-Threatening Clinical Entity Affecting the Young 340
MTMR4 SNVs modulate ion channel degradation and clinical severity in congenital long QT syndrome: insights in the mechanism of action of protective modifier genes 309
NOS1AP polymorphisms reduce NOS1 activity and interact with prolonged repolarization in arrhythmogenesis 296
Calmodulinopathy: Functional Effects of CALM Mutations and Their Relationship With Clinical Phenotypes 264
From patient-specific induced pluripotent stem cells to clinical translation in long QT syndrome Type 2 257
Genetic mechanisms of critical illness in COVID-19 253
Prevalence of cardiac amyloidosis among adult patients referred to tertiary centres with an initial diagnosis of hypertrophic cardiomyopathy 232
Investigation on Sudden Unexpected Death in the Young (SUDY) in Europe: results of the European Heart Rhythm Association Survey 229
Pulmonary hypertension due to a stiff left atrium: Speckle tracking equivalents of large V-waves 229
Clinical management of catecholaminergic polymorphic ventricular tachycardia the role of left cardiac sympathetic denervation 227
Generation of the human induced pluripotent stem cell (hiPSC) line PSMi003-A from a patient affected by an autosomal recessive form of Long QT Syndrome type 1 213
Mapping the human genetic architecture of COVID-19 204
Mexiletine Shortens the QT Interval in Patients With Potassium Channel-Mediated Type 2 Long QT Syndrome. 203
Long QT Syndrome and Brugada Syndrome : 2 aspects of the same disease? 202
Identification of a KCNQ1 polymorphism acting as a protective modifier against arrhythmic risk in long-QT syndrome 201
The expression of the rare caveolin-3 variant T78M alters cardiac ion channels function and membrane excitability 197
Identification of a targeted and testable antiarrhythmic therapy for long-QT syndrome type 2 using a patient-specific cellular model 194
Exercise Training-Induced Repolarization Abnormalities Masquerading as Congenital Long QT Syndrome 194
Condizioni cliniche associate ad anomalie dell'intervallo QT: Implicazioni cliniche [Clinical conditions associated with abnormal QT interval: clinical implications] 187
Partial Pericardial Agenesis Mimicking Arrhythmogenic Right Ventricular Cardiomyopathy 171
Biventricular arrhythmogenic cardiomyopathy: a paradigmatic case. 166
The KCNH2-IVS9-28A/G mutation causes aberrant isoform expression and hERG trafficking defect in cardiomyocytes derived from patients affected by Long QT Syndrome type 2 157
Infanticide vs. inherited cardiac arrhythmias. 156
Enhancing rare variant interpretation in inherited arrhythmias through quantitative analysis of consortium disease cohorts and population controls 150
The ICD for the long QT syndrome: which indications, complications, and results? 149
Response by Crotti et al to Letter Regarding Article, "genetic Modifiers for the Long-QT Syndrome: How Important Is the Role of Variants in the 3′ Untranslated Region of KCNQ1?" 145
An International Multicenter Evaluation of Type 5 Long QT Syndrome: A Low Penetrant Primary Arrhythmic Condition 143
Does pregnancy increase cardiac risk for LQT1 patients with the KCNQ1-A341V mutation? 142
A Primary Prevention Clinical Risk Score Model for Patients With Brugada Syndrome (BRUGADA-RISK) 142
Inherited cardiac arrhythmia syndrome. Role of potassium channels 140
A novel rare variant in SCN1Bb linked to Brugada syndrome and SIDS by combined modulation of Na(v)1.5 and K(v)4.3 channel currents 140
The Common Long QT Syndrome mutation KCNQ1/A341V causes unusually severe clinical manifestations in patients with different ethnic backgrounds: toward a mutation-specific risk stratification 139
The Long QT Syndrome 139
Role of common and rare variants in SCN10A: results from the Brugada syndrome QRS locus gene discovery collaborative study 138
Generation of the human induced pluripotent stem cell (hiPSC) line PSMi002-A from a patient affected by the Jervell and Lange-Nielsen syndrome and carrier of two compound heterozygous mutations on the KCNQ1 gene 138
The Jervell and Lange-Nielsen syndrome: natural history, molecular basis, and clinical outcome 137
Genetic Modifiers for the Long-QT Syndrome: How Important Is the Role of Variants in the 3′ Untranslated Region of KCNQ1? 136
Prevalence of the congenital long-qt syndrome 136
Brugada and Long QT Syndrome are two different diseases: True or False? 136
To be, or not to be engaged in sport activities, that is the amletic question for patients with coronary artery disease 136
SCN5A mutations in 442 neonates and children: genotype-phenotype correlation and identification of higher-risk subgroups. 135
Multiscale complexity analysis of the cardiac control identifies asymptomatic and symptomatic patients in long QT syndrome type 1 134
The genetics underlying acquired long QT syndrome: Impact for genetic screening 133
Mutation-Specific Risk in Two Genetic Forms of Type 3 Long QT Syndrome 133
Calmodulin mutations and life-threatening cardiac arrhythmias: Insights from the International Calmodulinopathy Registry 133
Gain of function mutation, S422L, in the KCNJ8-encoded cardiac K ATP channel Kir6.1 as a pathogenic substrate for J wave syndromes 132
Mutation analysis of the phospholamban gene in 315 South Africans with dilated, hypertrophic, peripartum and arrhythmogenic right ventricular cardiomyopathies 132
Gene symbol: KCNH2. Disease: Long QT syndrome in Novel human pathological mutations 131
Long and Short QT syndromes. 131
Neuroimmune crosstalk in the pathophysiology of hypertension. 131
A KCNH2 branch point mutation causing aberrant splicing contributes to an explanation of genotype-negative long QT syndrome 130
Cardiac potassium channel dysfunction in sudden infant death syndrome 130
Autonomic control of heart rate and QT interval variability influences arrhythmic risk in long QT syndrome type 1 130
The elusive link between LQT3 and Brugada syndrome: the role of flecainide challenge 129
KCNH2-K897T Is a Genetic Modifier of Latent Congenital Long-QT Syndrome 129
Phenotypic variability and unusual clinical severity of congenital long-QT syndrome in a founder population 128
Long and Short QT Syndromes 128
The role of genetics in primary ventricular fibrillation, inherited channelopathies and cardiomyopathies 127
Clinical and genetic heterogeneity of right bundle branch block and ST-segment elevation syndrome: A prospective evaluation of 52 families 127
Response to Letters Regarding Article, "clinical Management of Catecholaminergic Polymorphic Ventricular Tachycardia: The Role of Left Cardiac Sympathetic Denervation" 126
Low-pass filtering approach via empirical mode decomposition improves short scale entropy-based complexity estimation of QT interval variability in Long QT Syndrome Type 1 patients 126
A novel disease gene for Brugada syndrome: sarcolemmal membrane-associated protein gene mutations impair intracellular trafficking of hNav1.5 126
Arrhythmogenic calmodulin mutations disrupt intracellular cardiomyocyte Ca2+ regulation by distinct mechanisms 125
PREDESTINATION: PRimary vEntricular fibrillation and suDden dEath during a firST myocardIal iNfArcTION: Genetic basis 125
The genetics underlying idiopathic ventricular fibrillation: A special role for catecholaminergic polymorphic ventricular tachycardia? 125
Genetic of adult and fetal forms of Long QT Syndrome. 125
Unexplained sudden cardiac arrest in children: clinical and genetic characteristics of survivors 125
AKAP9 is a genetic modifier of congenital long-QT syndrome type 1 124
A refined multiscale self-entropy approach for the assessment of cardiac control complexity: Application to long QT syndrome type 1 patients 124
The E1784K mutation in SCN5A is associated with mixed clinical phenotype of type 3 long QT syndrome 123
Cardiac arrhythmias of genetic origin are important contributors to Sudden Infant Death Syndrome 123
Desmoplakin missense and non-missense mutations in arrhythmogenic right ventricular cardiomyopathy: Genotype-phenotype correlation 123
Impact of clinical and genetic findings on the management of young patients with Brugada syndrome 122
Novel Perspectives in Redox Biology and Pathophysiology of Failing Myocytes: Modulation of the Intramyocardial Redox Milieu for Therapeutic Interventions -A Review Article from the Working Group of Cardiac Cell Biology, Italian Society of Cardiology 121
Propranolol prevents life-threatening arrhythmias in LQT3 transgenic mice: implications for the clinical management of LQT3 patients 121
Congenital long QT syndrome 121
Cardiac sodium channel dysfunction in sudden infant death syndrome 119
QTc behavior during exercise and genetic testing for the long-QT syndrome 118
Founder populations with channelopathies and church records reveal all sorts of interesting secrets: Some are scientifically relevant 118
Invasive Hemodynamics of Hypertrophic Cardiomyopathy: Exercise Versus Isoproterenol 117
Left cardiac sympathetic denervation for catecholaminergic polymorphic ventricular tachycardia 116
Clinical Implications for Patients With Long QT Syndrome Who Experience a Cardiac Event During Infancy 116
Neural control of heart rate is an arrhythmia risk modifier in long QT syndrome 116
Novel calmodulin mutations associated with congenital long QT syndrome affect calcium current in human cardiomyocytes 115
Gene symbol: KCNH2. Disease: Long QT syndrome in Novel human pathological mutations 115
Reply to the Editor--Propranolol prevents life-threatening arrhythmias in LQT3 transgenic mice: implications for the clinical management of LQT3 patients 113
All LQT3 patients need an ICD. True or false? 113
Time, frequency and information domain analysis of heart period and QT variability in asymptomatic long QT syndrome type 2 patients 112
A comprehensive electrocardiographic, molecular, and echocardiographic study of Brugada syndrome: Validation of the 2013 diagnostic criteria 112
Malignant perinatal variant of long-QT syndrome caused by a profoundly dysfunctional cardiac sodium channel 111
Ion channel diseases in children: Manifestations and management 111
Prevalence of long-QT syndrome gene variants in sudden infant death syndrome 110
Who are the long-QT syndrome patients who receive an implantable cardioverter-defibrillator and what happens to them? Data from the European Long-QT Syndrome Implantable Cardioverter-Defibrillator (LQTS ICD) Registry 110
Sudden cardiac death in infancy: Focus on prolonged repolarization 109
Genetic association study of QT interval highlights role for calcium signaling pathways in myocardial repolarization 108
When genetic screening for your patient with long QT syndrome comes back negative, don't always take a no for a no 108
Abnormal myocardial expression of SAP97 is associated with arrhythmogenic risk 107
Totale 15.591
Categoria #
all - tutte 107.435
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 107.435


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020219 0 0 0 0 0 0 0 0 0 0 136 83
2020/20212.916 68 202 293 297 168 264 543 300 182 231 181 187
2021/20221.909 153 163 235 85 61 117 117 152 95 208 221 302
2022/20233.996 425 913 301 350 274 652 92 261 354 65 169 140
2023/20243.086 124 162 157 89 420 709 509 107 300 92 79 338
2024/20257.242 466 1.208 617 332 622 347 456 358 1.061 1.102 673 0
Totale 25.212